| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing xamoterol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Sympathomimetic compound |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Dopamine hydrochloride 40mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Dopamine hydrochloride 80mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine hydrochloride 1% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine hydrochloride 2% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine hydrochloride 1.9mg dental pellet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine hydrochloride 1.15mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine hydrochloride 0.5mg/in |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine hydrochloride 0.85mg/in |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine hydrochloride 1.15mg/in |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine hydrochloride 0.82mg/in |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine hydrochloride 0.5mg/inch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine 1mg/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine 0.5mg/mL injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine 1mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine 500mcg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine 2.0% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Adrenaline 5 mg/mL eye solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine 1.0% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine hydrochloride 0.108mg/cm |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine hydrochloride 0.6mg pellets |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine hydrochloride 1.7mg/in |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine hydrochloride 0.182mg/cm |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine hydrochloride 0.364mg/cm |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Norepinephrine 1mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Dexmedetomidine hydrochloride 100mcg/mL injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine 1mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Dopamine hydrochloride 160mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine hydrochloride 1mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Articaine hydrochloride 40mg/epinephrine 10mcg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine 10mcg/lidocaine hydrochloride 20mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine 20mcg/lidocaine hydrochloride 20mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine 10mcg/lidocaine hydrochloride 10mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine + lidocaine hydrochloride 10mcg/20mg injecti |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine + lidocaine hydrochloride 20mcg/20mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine 5mcg/lidocaine hydrochloride 15mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine bitartrate 5mcg/lidocaine hydrochloride 10mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine bitartrate + lidocaine hydrochloride 10mcg/20mg inj |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine bitartrate + lidocaine hydrochloride 20mcg/20mg inj |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine bitartrate + pilocarpine hydrochloride 1%/1%wv solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine bitartrate + pilocarpine hydrochloride 1%/4%wv solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine bitartrate + pilocarpine hydrochloride 1%/6%wv solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine bitartrate + pilocarpine hydrochloride 1%/2%wv solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Dopamine hydrochloride 400mg/glucose infusion solution 250mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Dopamine hydrochloride 800mg/glucose infusion solution 250mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Respiratory sympathomimetic agent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Respiratory epinephrine preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Corbadrine |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Bitolterol (substance) |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Isometheptene (substance) |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Ephedrine (substance) |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Phenylpropanolamine (substance) |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Iobenguane |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Dopamine receptor agonist |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Poisoning by sympathomimetic drug |
Causative agent (attribute) |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
1 |
| Poisoning by epinephrine |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Product containing dopamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Product containing epinephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Product containing sympathomimetic (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
1 |
| Lidocaine hydrochloride+epinephrine 0.5%/1:200,000 injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Product containing cocaine and epinephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride+epinephrine 2%/1:80,000 cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Product containing epinephrine and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Cocaine+epinephrine 5%/0.02% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine 5 mg/mL and guanethidine monosulfate 30 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Guanethidine monosulfate+epinephrine 1%/0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride+epinephrine 4% preservative free nasal drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 1%/epinephrine 1:200,000 injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 2%/epinephrine 1:200,000 injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 1.5%/epinephrine 1:200,000 injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 2%/epinephrine 1:500,000 injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 2%/epinephrine 1:100,000 injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Bupivacaine hydrochloride + epinephrine bitartrate 5mg/0.0091mg inject |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 1%/epinephrine 1:100,000 injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Product containing epinephrine and fluorouracil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine bitartrate + pilocarpine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Levosalbutamol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Dopamine hydrochloride 40mg/mL injection solution 100mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Dopamine hydrochloride 80mg/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Dopamine hydrochloride 40mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Dopamine hydrochloride 80mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Lidocaine 2%/epinephrine (1:200000) injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Dopamine hydrochloride 40mg/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Lidocaine 1%/epinephrine (1:200000) injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Zinc sulfate+epinephrine eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Product containing bupivacaine and epinephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Adrenaline 2 mg/mL and guanethidine monosulfate 10 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Guanethidine monosulfate+epinephrine 0.5%/0.1% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Guanethidine monosulfate+epinephrine 0.25%/0.05% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Bupivacaine+epinephrine 0.25%/1:200000 sterile wrapped injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Bupivacaine+epinephrine 0.5%/1:200000 sterile wrapped injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Adverse reaction to adrenaline, epinephrine |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Guanethidine monosulfate+epinephrine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Adverse reaction to sympathomimetic NOS |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Bupivacaine hydrochloride 0.5%/epinephrine 50micrograms 10mL (1:200000) injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Bupivacaine hydrochloride+epinephrine 0.75%/1:200000 injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Prilocaine hydrochloride 4%/epinephrine 200,000 injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Bupivacaine hydrochloride 5mg/epinephrine 5mcg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Bupivacaine hydrochloride + epinephrine 7.5mg/0.005mg solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]